PRESERVE Trial: Patients with Moderately Active RA Achieve and Maintain Low Disease Activity and Remission with Anti-TNF Therapy More Successfully than Those with High Disease Activity
RitaBuckley
Medical University of Vienna, Center of Rheumatic Diseases at Hietzing Hospital, Vienna, Austria
PRESERVE Trial: Patients with Moderately Active RA Achieve and Maintain Low Disease Activity and Remission with Anti-TNF Therapy More Successfully than Those with High Disease Activity
PRESERVE Trial: Patients with Moderately Active RA Achieve and Maintain Low Disease Activity and Remission with Anti-TNF Therapy More Successfully than Those with High Disease Activity